Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Sheep Myelin Basic Protein ELISA Kit (AC2839)
Cat.#: ASET-1428
Specifications
Description Sheep Myelin Basic Protein ELISA Kit allows for the in vitro quantitative determination of sheep Myelin Basic Protein concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Sheep Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1637 Human PPAR gamma ELISA Kit (AC3048) Quantitative inquiry ASET-1206 Human Substance P ELISA Kit (AC2617) Quantitative inquiry ASET-2197 Human HSD17B1 ELISA Kit (AC3608) Quantitative inquiry ASET-2365 Bovine IL-6 ELISA Kit (AC3776) Quantitative inquiry ASET-2364 Human Glutaminase ELISA Kit (AC3775) Quantitative inquiry ASET-1855 Rat Axin 2 ELISA Kit (AC3266) Quantitative inquiry ASET-2366 Human Wnt3a ELISA Kit (AC3777) Quantitative inquiry ASET-2377 Human SRD5A1 ELISA Kit (AC3788) Quantitative inquiry ASET-1311 Rat alpha Synuclein ELISA Kit (AC2722) Quantitative inquiry ASET-1541 Mouse Notch1 ELISA Kit (AC2952) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket